Literature DB >> 18410249

Structural biology of the tumor suppressor p53.

Andreas C Joerger1, Alan R Fersht.   

Abstract

The tumor suppressor protein p53 induces or represses the expression of a variety of target genes involved in cell cycle control, senescence, and apoptosis in response to oncogenic or other cellular stress signals. It exerts its function as guardian of the genome through an intricate interplay of independently folded and intrinsically disordered functional domains. In this review, we provide insights into the structural complexity of p53, the molecular mechanisms of its inactivation in cancer, and therapeutic strategies for the pharmacological rescue of p53 function in tumors. p53 emerges as a paradigm for a more general understanding of the structural organization of modular proteins and the effects of disease-causing mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18410249     DOI: 10.1146/annurev.biochem.77.060806.091238

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  250 in total

1.  CCAAT/Enhancer-binding protein beta DNA binding is auto-inhibited by multiple elements that also mediate association with p300/CREB-binding protein (CBP).

Authors:  Sook Lee; Maria Miller; Jon D Shuman; Peter F Johnson
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  Chaperoning of mutant p53 protein by wild-type p53 protein causes hypoxic tumor regression.

Authors:  Rajan Gogna; Esha Madan; Periannan Kuppusamy; Uttam Pati
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

3.  Pliable DNA conformation of response elements bound to transcription factor p63.

Authors:  Chen Chen; Natalia Gorlatova; Osnat Herzberg
Journal:  J Biol Chem       Date:  2012-01-12       Impact factor: 5.157

Review 4.  Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.

Authors:  Raj Kumar; Iain J McEwan
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

5.  Multiscale ensemble modeling of intrinsically disordered proteins: p53 N-terminal domain.

Authors:  Tsuyoshi Terakawa; Shoji Takada
Journal:  Biophys J       Date:  2011-09-20       Impact factor: 4.033

6.  Mapping the physical and functional interactions between the tumor suppressors p53 and BRCA2.

Authors:  Sridharan Rajagopalan; Antonina Andreeva; Trevor J Rutherford; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

7.  Restoration of DNA-binding and growth-suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway.

Authors:  Ricardo E Perez; Chad D Knights; Geetaram Sahu; Jason Catania; Vamsi K Kolukula; Daniel Stoler; Adolf Graessmann; Vasily Ogryzko; Michael Pishvaian; Christopher Albanese; Maria Laura Avantaggiati
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

8.  Design, synthesis and protein-targeting properties of thioether-linked hydrogen bond surrogate helices.

Authors:  Andrew B Mahon; Paramjit S Arora
Journal:  Chem Commun (Camb)       Date:  2011-09-28       Impact factor: 6.222

9.  Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2.

Authors:  Simon M Vogel; Matthias R Bauer; Andreas C Joerger; Rainer Wilcken; Tobias Brandt; Dmitry B Veprintsev; Trevor J Rutherford; Alan R Fersht; Frank M Boeckler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-03       Impact factor: 11.205

Review 10.  The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.

Authors:  Oleg Laptenko; David R Tong; James Manfredi; Carol Prives
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.